Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing the single result
Showing the single result
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Mean reversion in net discount rates
1 × $25.00 Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
1 × $25.00 Subtotal: $50.00